$CBPO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in China Biologic Products Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in China Biologic Products Holdings, Inc.. Get notifications about new insider transactions in China Biologic Products Holdings, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2017 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 100.57 | 54,049 | 5,435,708 | 395,347 | 449.4 K to 395.3 K (-12.03 %) |
| Mar 02 2017 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 100.69 | 62,604 | 6,303,597 | 449,396 | 512 K to 449.4 K (-12.23 %) |
| Dec 12 2016 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Option Exercise | M | 9.85 | 5,000 | 49,250 | 0 | |
| Dec 12 2016 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Option Exercise | M | 10.57 | 20,000 | 211,400 | 0 | |
| Dec 12 2016 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Buy | M | 9.85 | 5,000 | 49,250 | 45,000 | 40 K to 45 K (+12.50 %) |
| Dec 12 2016 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Buy | M | 10.57 | 20,000 | 211,400 | 40,000 | 20 K to 40 K (+100.00 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 124.32 | 21,092 | 2,622,157 | 24,782 | 45.9 K to 24.8 K (-45.98 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 124.32 | 21,092 | 2,622,157 | 24,782 | 45.9 K to 24.8 K (-45.98 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Yin Ming | Sr. Corporate Vice ... | Sell | S | 124.32 | 20,334 | 2,527,923 | 16,467 | 36.8 K to 16.5 K (-55.25 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Yin Ming | Sr. Corporate Vice ... | Sell | S | 124.32 | 20,334 | 2,527,923 | 16,467 | 36.8 K to 16.5 K (-55.25 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 124.32 | 8,400 | 1,044,288 | 32,242 | 40.6 K to 32.2 K (-20.67 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 124.32 | 8,400 | 1,044,288 | 32,242 | 40.6 K to 32.2 K (-20.67 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 124.32 | 1,968 | 244,662 | 0 | 2 K to 0 (-100.00 %) |
| Aug 17 2016 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Sell | S | 124.32 | 2,900 | 360,528 | 3,383 | 6.3 K to 3.4 K (-46.16 %) |
| Aug 12 2016 | CBPO | China Biologic Pro ... | Fang Min | Director | Sell | J | 0.00 | 1,305,526 | 0 | 6,674 | 1.3 M to 6.7 K (-99.49 %) |
| Aug 12 2016 | CBPO | China Biologic Pro ... | Li David Hui | Director | Grant | A | 0.00 | 269 | 0 | 269 | 538 to 269 (-50.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Grant | A | 0.00 | 9,000 | 0 | 18,000 | 9 K to 18 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Grant | A | 0.00 | 9,000 | 0 | 18,000 | 9 K to 18 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Shao Sean | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Shao Sean | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 111,250 | 66.3 K to 111.3 K (+67.92 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 111,250 | 66.3 K to 111.3 K (+67.92 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 30,000 | 0 | 71,250 | 41.3 K to 71.3 K (+72.73 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Grant | A | 0.00 | 150,000 | 0 | 310,000 | 160 K to 310 K (+93.75 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 7,500 | 0 | 20,750 | 13.3 K to 20.8 K (+56.60 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Yin Ming | SCVP | Grant | A | 0.00 | 30,000 | 0 | 72,500 | 42.5 K to 72.5 K (+70.59 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Chow Joseph | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Li David Hui | Director | Grant | A | 0.00 | 5,000 | 0 | 25,000 | 20 K to 25 K (+25.00 %) |
| Aug 08 2016 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
| Aug 02 2016 | CBPO | China Biologic Pro ... | Li David Hui | Director | Grant | A | 0.00 | 15,000 | 0 | 20,000 | 5 K to 20 K (+300.00 %) |
| Aug 02 2016 | CBPO | China Biologic Pro ... | Li David Hui | Director | Grant | A | 0.00 | 15,000 | 0 | 20,000 | 5 K to 20 K (+300.00 %) |
| Jun 08 2016 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Sell | S | 111.00 | 2,775,000 | 308,025,000 | 1,312,200 | 4.1 M to 1.3 M (-67.89 %) |
| Jun 08 2016 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Sell | S | 111.00 | 2,775,000 | 308,025,000 | 1,312,200 | 4.1 M to 1.3 M (-67.89 %) |
| Jun 08 2016 | CBPO | China Biologic Pro ... | Fang Min | Director | Sell | S | 111.00 | 2,775,000 | 308,025,000 | 1,312,200 | 4.1 M to 1.3 M (-67.89 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Option Exercise | M | 9.85 | 11,250 | 110,813 | 3,750 | |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Option Exercise | M | 12.26 | 40,000 | 490,400 | 15,000 | |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 113.40 | 11,705 | 1,327,347 | 35,642 | 47.3 K to 35.6 K (-24.72 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 113.83 | 14,858 | 1,691,286 | 47,347 | 62.2 K to 47.3 K (-23.89 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Buy | M | 12.26 | 40,000 | 490,400 | 62,205 | 22.2 K to 62.2 K (+180.14 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Option Exercise | M | 9.85 | 7,952 | 78,327 | 7,500 | |
| May 23 2016 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Option Exercise | M | 12.26 | 30,000 | 367,800 | 15,452 | |
| May 23 2016 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Sell | S | 113.40 | 8,645 | 980,343 | 31,801 | 40.4 K to 31.8 K (-21.37 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Sell | S | 113.83 | 10,973 | 1,249,057 | 40,446 | 51.4 K to 40.4 K (-21.34 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Buy | M | 12.26 | 30,000 | 367,800 | 51,419 | 21.4 K to 51.4 K (+140.06 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Option Exercise | M | 9.85 | 27,500 | 270,875 | 12,500 | |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 113.40 | 6,129 | 695,029 | 38,374 | 44.5 K to 38.4 K (-13.77 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 113.83 | 7,779 | 885,484 | 44,503 | 52.3 K to 44.5 K (-14.88 %) |
| May 23 2016 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Buy | M | 9.85 | 27,500 | 270,875 | 52,282 | 24.8 K to 52.3 K (+110.97 %) |
| Mar 15 2016 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 108.00 | 282 | 30,456 | 718 | 1,000 to 718 (-28.20 %) |
| Mar 10 2016 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 1,000 | 0 | 14,500 | 13.5 K to 14.5 K (+7.41 %) |
| Mar 09 2016 | CBPO | China Biologic Pro ... | Fang Min | Director | Sell | S | 107.00 | 4,257,000 | 455,499,000 | 4,087,200 | 8.3 M to 4.1 M (-51.02 %) |
| Mar 09 2016 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Sell | S | 107.00 | 4,257,000 | 455,499,000 | 4,087,200 | 8.3 M to 4.1 M (-51.02 %) |
| Mar 09 2016 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Sell | S | 107.00 | 4,257,000 | 455,499,000 | 4,087,200 | 8.3 M to 4.1 M (-51.02 %) |
| Feb 29 2016 | CBPO | China Biologic Pro ... | Li David Hui | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Option Exercise | M | 9.85 | 4,514 | 44,463 | 10,000 | |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Option Exercise | M | 9.61 | 10,000 | 96,100 | 14,514 | |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Option Exercise | M | 9.85 | 486 | 4,787 | 24,514 | |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Sell | S | 119.00 | 4,514 | 537,166 | 14,000 | 18.5 K to 14 K (-24.38 %) |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Buy | M | 9.85 | 4,514 | 44,463 | 18,514 | 14 K to 18.5 K (+32.24 %) |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Sell | S | 118.00 | 10,000 | 1,180,000 | 14,000 | 24 K to 14 K (-41.67 %) |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Buy | M | 9.61 | 10,000 | 96,100 | 24,000 | 14 K to 24 K (+71.43 %) |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Sell | S | 119.00 | 486 | 57,834 | 14,000 | 14.5 K to 14 K (-3.35 %) |
| Dec 08 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Buy | M | 9.85 | 486 | 4,787 | 14,486 | 14 K to 14.5 K (+3.47 %) |
| Nov 05 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 115.19 | 7,460 | 859,317 | 377,000 | 384.5 K to 377 K (-1.94 %) |
| Nov 05 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 115.63 | 88,531 | 10,236,840 | 384,460 | 473 K to 384.5 K (-18.72 %) |
| Nov 03 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 115.02 | 4,009 | 461,115 | 472,991 | 477 K to 473 K (-0.84 %) |
| Nov 03 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 111.01 | 8,882 | 985,991 | 477,000 | 485.9 K to 477 K (-1.83 %) |
| Oct 30 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 110.08 | 9,458 | 1,041,137 | 485,882 | 495.3 K to 485.9 K (-1.91 %) |
| Oct 30 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 110.23 | 61,660 | 6,796,782 | 495,340 | 557 K to 495.3 K (-11.07 %) |
| Oct 27 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 105.33 | 6,289 | 662,424 | 557,000 | 563.3 K to 557 K (-1.12 %) |
| Oct 27 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 105.21 | 53,253 | 5,602,684 | 563,289 | 616.5 K to 563.3 K (-8.64 %) |
| Oct 21 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 105.00 | 258 | 27,090 | 616,542 | 616.8 K to 616.5 K (-0.04 %) |
| Oct 21 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Sell | S | 105.03 | 200 | 21,005 | 616,800 | 617 K to 616.8 K (-0.03 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Option Exercise | M | 9.85 | 9,000 | 88,650 | 40,000 | |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Option Exercise | M | 9.85 | 1,000 | 9,850 | 49,000 | |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 94.56 | 9,000 | 851,040 | 24,782 | 33.8 K to 24.8 K (-26.64 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Buy | M | 9.85 | 9,000 | 88,650 | 33,782 | 24.8 K to 33.8 K (+36.32 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 97.08 | 11,304 | 1,097,392 | 24,782 | 36.1 K to 24.8 K (-31.33 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Buy | M | 9.85 | 1,000 | 9,850 | 36,086 | 35.1 K to 36.1 K (+2.85 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 99.29 | 6,786 | 673,782 | 0 | 6.8 K to 0 (-100.00 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Sell | S | 97.02 | 2,717 | 263,603 | 3,283 | 6 K to 3.3 K (-45.28 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Option Exercise | M | 9.85 | 13,134 | 129,370 | 45,452 | |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Option Exercise | M | 9.85 | 1,414 | 13,928 | 58,586 | |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Sell | S | 94.65 | 13,134 | 1,243,133 | 13,467 | 26.6 K to 13.5 K (-49.37 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Buy | M | 9.85 | 13,134 | 129,370 | 26,601 | 13.5 K to 26.6 K (+97.53 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Sell | S | 97.14 | 7,374 | 716,310 | 13,467 | 20.8 K to 13.5 K (-35.38 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Buy | M | 9.85 | 1,414 | 13,928 | 20,841 | 19.4 K to 20.8 K (+7.28 %) |
| Sep 16 2015 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 97.02 | 5,341 | 518,184 | 10,955 | 16.3 K to 11 K (-32.77 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Yin Ming | Sr. Corporate Vice ... | Grant | A | 0.00 | 20,000 | 0 | 60,000 | 40 K to 60 K (+50.00 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Grant | A | 0.00 | 6,000 | 0 | 15,000 | 9 K to 15 K (+66.67 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 5,000 | 0 | 18,250 | 13.3 K to 18.3 K (+37.74 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Grant | A | 0.00 | 9,000 | 0 | 22,500 | 13.5 K to 22.5 K (+66.67 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Grant | A | 0.00 | 6,000 | 0 | 15,000 | 9 K to 15 K (+66.67 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Shao Sean | Director | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 95,000 | 65 K to 95 K (+46.15 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Chow Joseph | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 20,000 | 0 | 57,500 | 37.5 K to 57.5 K (+53.33 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Grant | A | 0.00 | 80,000 | 0 | 220,000 | 140 K to 220 K (+57.14 %) |
| Aug 05 2015 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Grant | A | 0.00 | 6,000 | 0 | 15,000 | 9 K to 15 K (+66.67 %) |
| Jun 17 2015 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Sell | S | 100.28 | 2,645,000 | 265,227,375 | 8,344,200 | 11 M to 8.3 M (-24.07 %) |
| Jun 17 2015 | CBPO | China Biologic Pro ... | WP X Biologics LLC | Director | Sell | S | 100.28 | 2,645,000 | 265,227,375 | 8,344,200 | 11 M to 8.3 M (-24.07 %) |
| Jun 17 2015 | CBPO | China Biologic Pro ... | Li David Hui | Director | Sell | S | 100.28 | 2,645,000 | 265,227,375 | 8,344,200 | 11 M to 8.3 M (-24.07 %) |
| Mar 09 2015 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 2,000 | 0 | 13,250 | 11.3 K to 13.3 K (+17.78 %) |
| Nov 25 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Option Exercise | M | 12.26 | 8,000 | 98,080 | 7,500 | |
| Nov 25 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 68.95 | 8,000 | 551,600 | 3,036 | 11 K to 3 K (-72.49 %) |
| Nov 25 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Buy | M | 12.26 | 8,000 | 98,080 | 11,036 | 3 K to 11 K (+263.50 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Option Exercise | M | 17.00 | 500 | 8,500 | 19,500 | |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Sell | S | 62.75 | 7,080 | 444,270 | 0 | 7.1 K to 0 (-100.00 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Sell | S | 62.75 | 500 | 31,375 | 7,080 | 7.6 K to 7.1 K (-6.60 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Buy | M | 17.00 | 500 | 8,500 | 7,580 | 7.1 K to 7.6 K (+7.06 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Option Exercise | M | 9.85 | 7,500 | 73,875 | 15,500 | |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 62.75 | 7,500 | 470,625 | 3,036 | 10.5 K to 3 K (-71.18 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Buy | M | 9.85 | 7,500 | 73,875 | 10,536 | 3 K to 10.5 K (+247.04 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Option Exercise | M | 16.39 | 30,000 | 491,700 | 0 | |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Option Exercise | M | 12.26 | 40,000 | 490,400 | 30,000 | |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 62.75 | 2,500 | 156,875 | 20,000 | 22.5 K to 20 K (-11.11 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 62.75 | 30,000 | 1,882,500 | 22,500 | 52.5 K to 22.5 K (-57.14 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Sell | S | 62.75 | 40,000 | 2,510,000 | 52,500 | 92.5 K to 52.5 K (-43.24 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Buy | M | 16.39 | 30,000 | 491,700 | 92,500 | 62.5 K to 92.5 K (+48.00 %) |
| Nov 12 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Buy | M | 12.26 | 40,000 | 490,400 | 62,500 | 22.5 K to 62.5 K (+177.78 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 54.00 | 615 | 33,210 | 5,046 | 5.7 K to 5 K (-10.86 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Sell | S | 54.00 | 1,839 | 99,306 | 5,661 | 7.5 K to 5.7 K (-24.52 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 54.00 | 417 | 22,518 | 3,036 | 3.5 K to 3 K (-12.08 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Sell | S | 54.00 | 297 | 16,038 | 3,453 | 3.8 K to 3.5 K (-7.92 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 54.00 | 3,087 | 166,698 | 13,836 | 16.9 K to 13.8 K (-18.24 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Sell | S | 54.00 | 3,077 | 166,158 | 16,923 | 20 K to 16.9 K (-15.38 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Sell | S | 54.00 | 896 | 48,384 | 7,080 | 8 K to 7.1 K (-11.23 %) |
| Sep 16 2014 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Sell | S | 54.00 | 3,073 | 165,942 | 6,927 | 10 K to 6.9 K (-30.73 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Grant | A | 0.00 | 20,000 | 0 | 42,500 | 22.5 K to 42.5 K (+88.89 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Grant | A | 0.00 | 6,000 | 0 | 9,000 | 3 K to 9 K (+200.00 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Grant | A | 0.00 | 6,000 | 0 | 9,000 | 3 K to 9 K (+200.00 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 71,250 | 41.3 K to 71.3 K (+72.73 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 5,000 | 0 | 12,500 | 7.5 K to 12.5 K (+66.67 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Shao Sean | Director | Grant | A | 0.00 | 10,000 | 0 | 15,000 | 5 K to 15 K (+200.00 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Grant | A | 0.00 | 9,000 | 0 | 13,500 | 4.5 K to 13.5 K (+200.00 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Yang Gang CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 20,000 | 0 | 38,750 | 18.8 K to 38.8 K (+106.67 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Yeung Albert | Director | Grant | A | 0.00 | 6,000 | 0 | 9,000 | 3 K to 9 K (+200.00 %) |
| Aug 28 2014 | CBPO | China Biologic Pro ... | Gao David | Chief Executive Off ... | Grant | A | 0.00 | 80,000 | 0 | 140,000 | 60 K to 140 K (+133.33 %) |
| Sep 16 2013 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Sell | S | 25.00 | 2,524 | 63,100 | 4,976 | 7.5 K to 5 K (-33.65 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Tong Zhijun | Director | Grant | A | 0.00 | 6,000 | 0 | 11,000 | 5 K to 11 K (+120.00 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Liu Zhijing CBPO | Corporate Vice Pres ... | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Lu Yungang | Director | Grant | A | 0.00 | 9,000 | 0 | 19,000 | 10 K to 19 K (+90.00 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Liu Wenfang | Director | Grant | A | 0.00 | 6,000 | 0 | 13,500 | 7.5 K to 13.5 K (+80.00 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Shao Sean | Director | Grant | A | 0.00 | 10,000 | 0 | 27,500 | 17.5 K to 27.5 K (+57.14 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Yin Ming | Senior Corporate VP | Grant | A | 0.00 | 20,000 | 0 | 30,000 | 10 K to 30 K (+200.00 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Yang Ming | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 55,000 | 25 K to 55 K (+120.00 %) |
| Aug 20 2013 | CBPO | China Biologic Pro ... | Zhang Le | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |